抗感染重组合异种骨对犬污染性桡骨缺损的一期植骨修复作用

目的探讨抗感染重组合异种骨(anti-infective reconstituted bone xenograft,ARBX)对犬污染性桡骨缺损的一期植骨修复的效果. 方法在重组合异种骨(reconstituted bone xenograft,RBX)基础上,结合抗生素局部缓释技术,制备具有较强抗感染能力和较高成骨作用的ARBX.取成年杂种犬8只,于双侧桡骨中上段制成15 mm节段性骨缺损,在缺损处注入5×106 CFU/ml金黄色葡萄球菌1 ml,静置15分钟后,于双侧缺损区分别植入ARBX、RBX,并用钢板固定.术后6个月对存活的6只犬进行取材,通过解剖学、X线片、组织学及细菌学检查,比较ARBX和RBX一期植骨修复犬污染性桡骨缺损的效果. 结果术后6个月,ARBX侧有5只完全修复,1只中央部3 mm缺损未修复,均无骨髓炎表现,标本细菌培养均为阴性.RBX侧有1只部分修复,5只未能修复,残留8～13 mm缺损,均有明显骨髓炎表现,标本细菌培养均为阳性. 结论 ARBX具有较高成骨活性和较强的抗菌能力,能够一期植骨修复细菌污染性骨缺损.     

同种异体胎颅骨结合碱性成纤维细胞生长因子移植治疗骨不连

目的寻找一种治疗骨不连接所需植骨材料,利用碱性成纤维细胞生长因子的活性诱导作用,促进骨修复.方法13例成人骨不连患者,选择4-10个月龄胎颅骨（FCB）作可吸收载体,结合碱性成纤维细胞生长因子（bFGF）制备成复合碱性成纤维细胞生长因子胎颅骨（bFGF/FCB）,植入受骨区,以适当的内固定重新构建骨修复支架.结果所有患者均得到骨性修复,且成骨效应明显.结论胎颅骨作为植骨材料既可以起到植骨作用,增大植骨面,增加骨再生诱发点,屏蔽了骨断面,也避免了自体植骨的手术创伤;碱性成纤维细胞生长因子可以诱导和促进骨修复,二者复合物是治疗骨不连接的一种较好材料.     

长段同种异体骨与自体活骨复合移植的实验研究

目的 研究长段同种异体骨与带血管腓骨套叠式复合骨移植体的愈合机制和规律。方法 采用健康成年杂种犬36只胫骨结节下切除3．0cm骨干和骨膜实验动物模型。随机分为实验组和对照组。实验组植入深低温保存的同种异体骨与带血管自体腓骨，对照组仅植入深低温保存的同种异体骨，均用7孔93cmAO加压钢板内固定及石膏外固定。术后1、2、3、4个月分别行X线摄片、ECT检查、大体标本及组织学观察。结果 X线示实验组较同时期对照组异体骨吸收、新骨形成明显，第4个月实验组宿主骨一异体骨接合部愈合率83．3％，对照组未愈合或不愈合。ECT检查：实验组较同期对照组骨代谢活跃，但变化规律相似，均为术后1、2个月活跃，于第2个月达高峰，第3、4个月呈下降趋势。组织学观察：实验组较同期对照组异体皮质骨髓腔内壁及哈佛管内的内吸收、成骨活动显著增强。结论 长段同种异体骨与带血管自体腓骨复合移植修复骨缺损效果良好，带血管自体腓骨能促进长段同种异体骨的血管化，加速其爬行替代过程。     

骨髓移植诱导免疫耐受家兔全耳同种移植

目的　为了减轻免疫诱导过程中对受体的侵袭 ,进一步探讨以家兔为动物模型 ,通过异体骨髓移植诱导同种皮肤移植免疫耐受。方法　通过骨髓腔内直接注射异体骨髓细胞 ,进行骨髓移植。结果　皮片的平均存活时间是 (88.0± 6 .0 )天 (P <0 .0 0 1 )。为了探讨其普遍性 ,我们用此诱导方法 ,还进行了同种全耳移植。平均存活时间是 (1 4 6 .0± 1 5 .1 )天 ,并有 1只移植耳存活时间已超过 1年 ,未见任何排斥反应。结论　本研究证明了以家兔为动物模型 ,在不使用免疫抑制剂的情况下 ,通过骨髓腔内直接注射异体骨髓细胞 ,进行骨髓移植的方法 ,不仅在皮肤移植上可以诱导长期稳定的特异性免疫耐受 ,而且在实质性器官耳的同种移植上取得了良好的效果     

Bone Mineral Density in the Proximal Femur and Contralateral Knee After Total Knee Arthroplasty

Osteoarthrosis (OA) is often associated with pain and disability, which are relieved after total knee arthroplasty (TKA), but the nature of bone changes associated with OA is controversial. We examined preoperative hip and contralateral knee bone mineral density (BMD) in patients requiring TKA and monitored the BMD changes postoperatively. Sixty-nine patients, scheduled to have TKA for osteoarthrotic knees, had both hips and contralateral knee BMD measured by dual-energy X-ray absorptiometry (DXA) at the time of operation (baseline) and at 1 yr after operation. X-rays of the knee joints were also taken to evaluate the severity of OA. Preoperatively, 27% and 38% of the patients had total hip BMD Z-score more than 1 SD in the operated side and contralateral hips, respectively. In all regions of interest (ROI), the mean baseline BMD of the affected side proximal femur was significantly lower than that of the contralateral side (p < 0.0005-0.019). The severity of OA was not associated with BMD. During 1-yr follow-up, the postoperative knee status and the physical activity of the patients (AKS score) improved. However, neither the hip nor the nonoperated knee BMDs increased. Knee OA is associated with significantly lower BMD values in the affected side compared with the contralateral hip, and these levels remained similar or decreased during a 1-yr follow-up. We conclude that improved mobility after TKA does not improve the effects of preoperative disuse-associated bone loss in the short term.     

逆行交锁髓内钉治疗股骨远段骨折

目的 总结股骨逆行交锁髓内钉应用的适应证、优点及其疗效。方法 2001年6月～2003年6月，采用切开复位股骨逆行交锁髓内钉内固定，治疗股骨远段骨折21例，早期行膝关节功能锻炼。结果 18例获随访，全部骨性愈合，功能恢复良好，无膝痛、跛行、膝关节僵直等。结论 股骨逆行交锁髓内钉治疗股骨远段骨折具有明显优势，固定牢固、坚强，功能恢复快，并发症少等优点，手术不需要C臂X线机和骨科手术牵引床，适合基层医院临床应用。     

大鼠骨髓间充质干细胞转染人TH基因的实验研究

目的评价酪氨酸羟化酶(tyrosine hydroxylase,TH)基因修饰骨髓间充质干细胞(mesenchymalstem cells,MSCs)后TH的表达情况及转染TH基因对MSCs的影响.方法构建含人TH基因的pCMV/hTH质粒,用脂质体转染原代培养的大鼠MSCs;Western blot及免疫细胞化学染色鉴定TH基因的表达及MSCs的分化情况;MTT比色法测定转染后的MSCs细胞活性,并与未转染的MSCs进行细胞活性比较.结果构建的pCMV/hTH质粒经ECoRI酶切后产生1.9okb和5.3kb的片段,与回收的目的基因及载体基因片段大小相符;转基因后的MSCs Western blot及免疫细胞化学染色显示TH染色阳性;转染后MSCs未见有NeuN,GFAP的表达;MTT比色法测定细胞活性,未转染与转染者差异无显著性.结论构建的TH基因能在体外培养的鼠MSCs中较好的表达,转染不会诱导MSCs向神经样细胞分化,对MSCs细胞活性无明显影响.     

手法复位治疗移位的跟骨关节内骨折

移位的跟骨关节内骨折的治疗长期以来一直是一个较为困难的问题，近年来多提倡手术切开复位内固定治疗。我院自1996—2001年采用手法复位治疗移位跟骨关节内骨折29例，效果满意，报告如下。     

QCT骨密度测量的质量控制及意义

目的目前国内对QCT骨密度测量的质量控制研究较少，本文介绍了QCT骨密度测量的准确度、精密度试验方法和意义。方法使用东芝CT机自带体模和软件为测量工具，测量四川大学华西骨质疏松研究中心等研制的QCT骨体模（称四川体模）的骨密度值。四川体模固定于15cm深的水浴中模拟人体腰椎，东芝体模置于水浴容器与扫描床面之间，按照人腰椎QCT骨密度测量相同的条件和方法进行操作，每日1次对测量体模连续测量25日，计算SD和CV，分别以25次测量125d25次测量／1d基线作3m的shewhart图。结果测量四川体模从小到大三管骨密度分别的准确度误差为-60．4％、-39．1％和-13．6％，其分别的校正系数为2．69、1．64、1．15，相关系数为0．9966，回归方程Y=35．6＋0．958X（X为测量骨密度，Y为校正后骨密度）。本型QCT机骨密度测量的25次／1d及25次，25d精密度误差分别为1．25～5．54％和1．98～7．87％。25次125d的精密度误差要大于25次，d，显示机器一日内精密度误差变化小，随时间延长其变化增大。以25次125d的结果为基线绘制的shewhart图优于25次/d。结论一切QCT骨密度测量都应进行质量控制，准确度必须予以校正，精密度试验应在此基础上进行。这样结果才真实、科学、可靠并具有可比性。     

Disaggregation of bone into crystals

Summary The sizes, shapes, and organizational states of the crystals in bone are studied by systematic disaggregation of the mineral phase. This is achieved by oxidizing the organic phase with sodium hypochlorite, dispersing the resultant particles by sonication, and separating the crystal aggregates from the crystal monomers by gravity setting in ethanol. Six different bones are compared. Bones in which crystals are intimately associated with the collagen fibrils mostly disaggregate into crystal monomers. In dense bones, where the crystals are mostly located between fibrils, they tend to persist as “fused” aggregates. All the crystals are tabular or plate-shaped. In bones in which the majority of crystals are associated with the collagen fibrils, just less than 90% of the crystals are shorter than about 450 ? in length. Their widths are on the average about 250 ?, almost an order of magnitude larger than the diameters of individual gap regions within the collagen fibril. The notion that one crystal is located in one gap region is therefore untenable and a reevaluation of the relations between collagen and mineral in bone is necessary.